# Oruka Therapeutics, Inc.: filings

ORKA · Nasdaq · CIK 907654 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/orka.md) · [Financials](/companies/orka/financials.md) · [Filings](/companies/orka/filings.md) · [Insiders](/companies/orka/insiders.md)

## Reports and events: 389 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 271, 8-K 262, 3 54, 10-Q 53, SC 13G/A 47, 424B4 46, 424B5 24, SC 13G 24, CT ORDER 23, DEFA14A 22, CORRESP 21, DEF 14A 20, 10-K 18, 144 17, 425 16, EFFECT 15, UPLOAD 15, S-3 12, SC 13D/A 10, SCHEDULE 13G/A 9, 8-K/A 8, D 8, SCHEDULE 13G 8, S-8 7, 424B3 6, ARS 5, SC 13D 5, PRE 14A 4, S-3/A 4, SCHEDULE 13D/A 4, S-1 3, S-1/A 3, S-4/A 3, 10-Q/A 2, 5 2, POS AM 2, SEC STAFF LETTER 2, 10-K/A 1, 3/A 1, 424B7 1, 4/A 1, RW 1, S-4 1, S-8 POS 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-26 | 08:00 ET | [8-K](/filings/0001213900-26-112281.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-112281 |
| 2026-08-24 | 16:06 ET | [8-K](/filings/0001213900-26-093021.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-093021 |
| 2026-08-10 | 16:06 ET | [10-Q](/filings/0001213900-26-087231.md) | Quarterly report, period 2026-06-30 | 0001213900-26-087231 |
| 2026-08-10 | 07:00 ET | [8-K](/filings/0001213900-26-086933.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-26-086933 |
| 2026-07-01 | 21:30 ET | [SCHEDULE 13D/A](/filings/0001104659-26-080010.md) | Ownership report, active investor, amended | 0001104659-26-080010 |
| 2026-06-04 | 16:15 ET | [8-K](/filings/0001213900-26-065294.md) | 5.07 Shareholder vote results | 0001213900-26-065294 |
| 2026-06-01 | 16:01 ET | [8-K](/filings/0001213900-26-063481.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-063481 |
| 2026-05-13 | 16:01 ET | [10-Q](/filings/0001213900-26-055769.md) | Quarterly report, period 2026-03-31 | 0001213900-26-055769 |
| 2026-05-04 | 18:00 ET | [SCHEDULE 13D/A](/filings/0001104659-26-055049.md) | Ownership report, active investor, amended | 0001104659-26-055049 |
| 2026-04-30 | 16:17 ET | [8-K](/filings/0001213900-26-050249.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-050249 |
| 2026-04-27 | 08:00 ET | [8-K](/filings/0001213900-26-047743.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-047743 |
| 2026-04-17 | 16:10 ET | [DEF 14A](/filings/0001213900-26-045159.md) | Proxy statement, period 2026-06-02 | 0001213900-26-045159 |
| 2026-03-12 | 16:03 ET | [10-K](/filings/0001213900-26-026929.md) | Annual report, period 2025-12-31 | 0001213900-26-026929 |
| 2025-12-11 | 16:10 ET | [8-K](/filings/0001213900-25-120676.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-120676 |
| 2025-11-12 | 16:02 ET | [10-Q](/filings/0001213900-25-109182.md) | Quarterly report, period 2025-09-30 | 0001213900-25-109182 |
| 2025-09-22 | 16:26 ET | [8-K](/filings/0001213900-25-090129.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-090129 |
| 2025-09-19 | 18:56 ET | [SCHEDULE 13D/A](/filings/0001104659-25-091774.md) | Ownership report, active investor, amended | 0001104659-25-091774 |
| 2025-08-11 | 16:01 ET | [10-Q](/filings/0001213900-25-074281.md) | Quarterly report, period 2025-06-30 | 0001213900-25-074281 |
| 2025-07-01 | 16:01 ET | [8-K](/filings/0001213900-25-060352.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-060352 |
| 2025-06-03 | 16:00 ET | [8-K](/filings/0001213900-25-050756.md) | 5.07 Shareholder vote results | 0001213900-25-050756 |
| 2025-05-14 | 16:02 ET | [10-Q](/filings/0001213900-25-043279.md) | Quarterly report, period 2025-03-31 | 0001213900-25-043279 |
| 2025-04-18 | 15:00 ET | [DEF 14A](/filings/0001213900-25-033316.md) | Proxy statement, period 2025-06-02 | 0001213900-25-033316 |
| 2025-03-10 | 19:00 ET | [SCHEDULE 13D/A](/filings/0001213900-25-022364.md) | Ownership report, active investor, amended | 0001213900-25-022364 |
| 2025-03-06 | 16:02 ET | [10-K](/filings/0001213900-25-021165.md) | Annual report, period 2024-12-31 | 0001213900-25-021165 |
| 2025-02-05 | 16:00 ET | [8-K](/filings/0001213900-25-010525.md) | 1.01 Entry into a material agreement | 0001213900-25-010525 |
| 2024-12-19 | 07:16 ET | [8-K](/filings/0001213900-24-110303.md) | 1.01 Entry into a material agreement | 0001213900-24-110303 |
| 2024-11-21 | 18:30 ET | [SC 13D/A](/filings/0001213900-24-101117.md) | Ownership report, active investor, amended | 0001213900-24-101117 |
| 2024-11-18 | 16:10 ET | [8-K](/filings/0001213900-24-099645.md) | 5.07 Shareholder vote results | 0001213900-24-099645 |
| 2024-11-14 | 16:56 ET | [8-K](/filings/0001213900-24-098530.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-098530 |
| 2024-11-14 | 06:37 ET | [S-1](/filings/0001213900-24-097737.md) | Registration statement | 0001213900-24-097737 |
| 2024-11-13 | 16:01 ET | [10-Q](/filings/0001213900-24-097443.md) | Quarterly report, period 2024-09-30 | 0001213900-24-097443 |
| 2024-10-22 | 16:15 ET | [SC 13D/A](/filings/0000902664-24-005943.md) | Ownership report, active investor, amended | 0000902664-24-005943 |
| 2024-10-18 | 16:11 ET | [DEF 14A](/filings/0001140361-24-043698.md) | Proxy statement, period 2024-11-14 | 0001140361-24-043698 |
| 2024-10-04 | 16:05 ET | [8-K](/filings/0001213900-24-085543.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-24-085543 |
| 2024-09-13 | 16:57 ET | [SC 13D/A](/filings/0001213900-24-078635.md) | Ownership report, active investor, amended | 0001213900-24-078635 |
| 2024-09-13 | 16:02 ET | [8-K](/filings/0001213900-24-078549.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-078549 |
| 2024-09-06 | 17:08 ET | [SC 13D](/filings/0001213900-24-076599.md) | Ownership report, active investor | 0001213900-24-076599 |
| 2024-09-05 | 17:18 ET | [8-K](/filings/0001213900-24-076184.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-24-076184 |
| 2024-08-27 | 19:51 ET | [8-K](/filings/0001213900-24-072683.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-072683 |
| 2024-08-23 | 16:35 ET | [8-K](/filings/0001213900-24-072251.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-072251 |
| 2024-08-16 | 16:25 ET | [8-K](/filings/0001213900-24-070263.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-070263 |
| 2024-08-15 | 16:15 ET | [8-K](/filings/0001213900-24-069662.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-069662 |
| 2024-08-01 | 16:25 ET | [8-K](/filings/0000950170-24-089329.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-089329 |
| 2024-08-01 | 16:05 ET | [10-Q](/filings/0000950170-24-089246.md) | Quarterly report, period 2024-06-30 | 0000950170-24-089246 |
| 2024-07-09 | 17:01 ET | [8-K](/filings/0001213900-24-060156.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-060156 |
| 2024-04-25 | 16:25 ET | [8-K](/filings/0000950170-24-048364.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-048364 |
| 2024-04-25 | 16:15 ET | [10-Q](/filings/0000950170-24-048329.md) | Quarterly report, period 2024-03-31 | 0000950170-24-048329 |
| 2024-04-23 | 16:20 ET | [8-K](/filings/0000950170-24-046918.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-046918 |
| 2024-04-05 | 16:05 ET | [SC 13D](/filings/0000902664-24-002769.md) | Ownership report, active investor | 0000902664-24-002769 |
| 2024-04-04 | 16:30 ET | [8-K](/filings/0000950170-24-041846.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-041846 |

Page 1 of 8. [Older](/companies/orka/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 08:01 ET. No prices; not investment advice.